🏛️ Verified NIH Record • Updated 2026-08-10
Sacral Neuromodulation for Male Overactive Bladder (MOAB) (NCT06511141)
Sacral Neuromodulation for Male Overactive Bladder
🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Axonics, Inc.
🩺 Plain-English Summary (8th-Grade Level)
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (22 Sites)
- University of Alabama at Birmingham — Birmingham, Alabama
- Urology Associates — Fairhope, Alabama
- Mayo Clinic — Scottsdale, Arizona
- USNC — Mountain View, California
- Tri Valley Urology — Murrieta, California
- University of Miami — Miami, Florida
- AdventHealth — Orlando, Florida
- Advanced Urology Institute — Oxford, Florida
- Louisiana State University — New Orleans, Louisiana
- WK Clinical Research — Shreveport, Louisiana
- Anne Arundel Urology — Annapolis, Maryland
- Wayne State University — Detroit, Michigan
- Mayo Clinic — Rochester, Minnesota
- Integrated Medical Professionals — New York, New York
- Associated Urologists of North Carolina (AUNC) — Raleigh, North Carolina
- University Hospitals Cleveland — Cleveland, Ohio
- Utica Park Urology — Tulsa, Oklahoma
- MidLantic Urology — Bala-Cynwyd, Pennsylvania
- Lowcountry Urology Clinics — North Charleston, South Carolina
- Urology Partners of North Texas (UPNT) — Arlington, Texas
- Texas Oncology — Houston, Texas
- Potomac Urology — Woodbridge, Virginia
📞 Contact the Study Coordinator
Phone: (714) 225-0903
Email: catherine.cabiling@bsci.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overactive Bladder
- Reduced-dose Botox for Urgency Incontinence Among Elder Females — Birmingham, Alabama
- Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections — Louisville, Kentucky
- A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections — Cincinnati, Ohio
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease — Decatur, Georgia
- Add-On ZIDA Sock Therapy for Overactive Bladder — Charleston, South Carolina
- Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder — Bethesda, Maryland
Explore by condition: All Overactive Bladder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.